The performance rights will be given, assuming the following...
a. LC remains employed by the company and...
b. she meets annual Corporate Performance Goals (these are set by the Board)
The performance goals were connected to clinical development (not MC nor business deals etc).
For FY2024...LC received a $389,147 performance bonus. Performance milestones were... capital raise, partnering and collaboration activities, azer-cel, CF33, and PD1 Vaxx clinical development. (taken from annual report)
For FY2023...LC received a $243,750 performance bonus. Performance milestones were... capital raise, partnering and collaboration activities, PD1 Vaxx and CF33 clinical development. taken from annual report)
- Forums
- ASX - By Stock
- IMU
- Ann: Notice of Annual General Meeting/Proxy Form
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

Ann: Notice of Annual General Meeting/Proxy Form, page-130
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 0.012 |
39 | 12054746 | 0.011 |
123 | 37475571 | 0.010 |
38 | 20531668 | 0.009 |
14 | 4320747 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3258567 | 9 |
0.014 | 11336079 | 44 |
0.015 | 6830166 | 21 |
0.016 | 6274494 | 28 |
0.017 | 7081669 | 12 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online